Molecular simulation methods in drug discovery: a prospective outlook

Area of Science:

• Computational chemistry and molecular modeling
• Drug discovery and development
• Biophysics and structural biology

Background:

• Molecular simulations have become integral to modern drug discovery.
• Increasing computational power and algorithmic advancements are driving their adoption.
• These methods offer significant potential to enhance productivity in pharmaceutical research.

Purpose of the Study:

• To forecast key advancements in molecular modeling for drug discovery over the next 25 years.
• To highlight areas where improvements will significantly impact drug development pipelines.
• To project the future scope and success rates of target-based drug discovery.

Main Methods:

• Review and projection of trends in computational resources and algorithms.
• Discussion of novel methods for sampling rare events in molecular dynamics.
• Consideration of higher levels of theory for enhanced simulation accuracy.

Main Results:

• Anticipated improvements in handling target flexibility and ligand binding.
• Enhanced accuracy in predicting target druggability, broadening discovery scope.
• Increased precision in protein-ligand binding affinity predictions.

Conclusions:

• Molecular modeling advancements will lead to more successful hit identification.
• Lead optimization processes will become more efficient and effective.
• The integration of advanced molecular simulations will reshape the future of drug discovery.